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Background: The Wnt (Wg/Wnt) signaling cascade plays an important role in tumorigenesis. Our previous report
indicated that aberrant localization of β-catenin proteins was a feature of pterygia. Therefore, this study aimed to analyze
the association of β-catenin protein and expression of a downstream gene, cyclin D1, in pterygial tissues.
Methods: Using immunohistochemistry, β-catenin and cyclin D1 protein expression was studied, in 150 pterygial
specimens and 30 normal conjunctivas.
Results: Seventy-three (48.7%) and 60 (40.0%) pterygial specimens tested positive for β-catenin and cyclin D1 protein
expression, respectively. Cyclin D1protein expression was significantly higher in β-catenin-nuclear/cytoplasmic positive
groups than in β-catenin membrane positive and negative groups (p<0.0001). In addition, cyclin D1 expression was
significantly higher in the fleshy group than in the atrophic and intermediate groups (p=0.006).
Conclusions: Our study demonstrated that β-catenin expressed in nuclei/cytoplasm increases cyclinD1 protein expression,
which invokes pterygial cell proliferation.
Pterygium  has  long  been  considered  a  degenerative
disease. However, the p53 protein was found to be abnormally
expressed  in  epithelium;  consequently,  pterygium  is  now
considered  to  be  a  UV  exposure-related  uncontrolled  cell
proliferation that is similar to a tumor [1-7].
Several adhesion molecules, including cadherin, cell-cell
adhesion molecules (CAMs), selectin, and integrin, maintain
tissue architecture [8]. E-cadherin (120 kDa; chromosome
16q),  a  transmembrane  protein,  plays  a  role  in  organ
morphogenesis,  tissue  formation,  and  proper  development
during embryogenesis [9]. The extracellular domain of E-
cadherin  connects  neighboring  cells  that  share  adherent
junctions through calcium-dependent homophilic interactions
[9].  The  cytoplasmic  portion  of  E-cadherin  links  the
cytoskeleton  via  the  proteins  α-catenin,  β-catenin,  and
p120ctm  [10].  β-catenin  not  only  contributes  to  cellular
adhesion but also is a central component in the Wingless/Wnt
(Wg/Wnt) signaling cascade, an important control system for
axis  determination  and  organogenesis  during  early
development [11,12].
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In the absence of a mitotic signal, free cytoplasmic β-
catenin  is  degraded  by  the  ubiquitin-proteasome  system
following phosphorylation by the protein complex, which is
composed  of  adenomatous  polyposis  coli  (APC)  tumor
suppresser  protein,  Axin,  and  serine  threonine  glycogen
synthetase kinase (GSK-3β) [13]. This mechanism ensures a
low level of free cytoplasmic β-catenin. However, with the
appearance  of  mitotic  signals  (e.g.,  Wnt  protein)  or  with
reduced expression of E-cadherin, the levels of free β-catenin
in the cytoplasm begin to increase. The binding of the Wnt
protein to its cognate frizzled receptor leads to activation of
the dishevelled (Dsh) protein, which then down-regulates the
APC-Axin-  GSK-3β  protein  complex  [14].  Hence,
cytoplasmic β-catenin evades degradation and accumulates in
the cytoplasm [15,16].
In addition, reduced expression of E-cadherin leads to
both the decomposition of the E-cadherin-catenin complex
and an increase in free cytoplasmic β-catenin. E-cadherin also
mediates  epithelial  cellular  adhesion.  When  the  free
cytoplasmic  β-catenin  increases,  it  eventually  translocates
into the nucleus and binds with transcription factors LEF
(Lymphoid  Enhancer  Factor)  and  TCF  (T  Cell  Factor),
resulting in the activation of target genes [17,18] such as
cyclin D1 and c-myc, are responsible for cell proliferation and
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2733neoplastic transformation [19,20]. By this process, activation
of  cyclinD1  by  β-catenin  contributes  to  epithelial
differentiation.
Cyclin D1 is a well known cell cycle control gene that
promotes  cell  cycle  progression  through  the  G1-phase  by
forming  active  holoenzymes  with  CDK  (cyclin-dependent
kinase) 4 and CDK6 and leads to phosphorylation of pRb
(retinoblastoma protein) [21]. Phosphorylation causes pRb to
release the E2F transcription factor, which can then activate
genes essential for progression through the G1–S transition and
S-phase [22].
Our  previous  report  indicated  that  promoter
hypermethylation  of  E-cadherin  may  be  involved  in  the
reduction  of  E-cadherin  protein  expression  in  pterygium
[23]. We also provided evidence to show that the aberrant
protein localization of β-catenin was detected in pterygium
[23]. As a result of our findings, we suggest that changes in
β-catenin  signaling  indeed  play  a  causative  role  in  the
development of pterygium.
In  the  present  study,  we  hypothesized  that  β-catenin
expressed  in  nuclei/cytoplasm  could  increase  cyclin  D1
protein expression to involve the formation of pterygia. To
test these hypotheses, we analyzed both the expression of β-
catenin  and  cyclin  D1  in  pterygium  and  the  relationship
between β-catenin protein localization and cyclin D1 protein
expression.
METHODS
Study subjects: Pterygial samples were harvested from 150
patients undergoing pterygium surgery and the patients were
asked to submit a written informed consent approved by the
Institutional Review Board. Patients in whom the apex of the
pterygium had invaded the cornea by more than 1 mm were
included in this study. The pterygia were classified into grades
1, 2, or 3 based on slit-lamp biomicroscopy evaluation. Grade
1 (“atrophic”) had clearly visible episcleral vessels under the
body of the pterygium; grade 2 (“intermediate”) had partially
visible episcleral vessels under the body of the pterygium;
grade  3  (“fleshy”)  had  totally  obscured  episcleral  vessels
underlying the body of the pterygium. The controls included
normal  conjunctival  samples  collected  from  the  superior
conjunctiva of 15 patients and the medial conjunctiva of 15
patients without pterygium and pinguecula; all patients were
undergoing cataract or vitreoretinal surgery. There were 87
males and 63 females in the pterygium group (age range=55
−82 years, means=65.7 years), and there were 15 males and
15  females  in  the  control  group  (age  range=55–75  years,
mean=62.8  years).  Normal  conjunctival  samples  were
collected from bulbar conjunctivas. All pterygial specimens
came from primary pterygia. All specimens were fixed in
formalin and paraffin embedded.
Immunohistochemistry: All sections were deparaffinized in
xylene, sequentially rehydrated through serial dilutions of
alcohol and washed in phosphate-buffered saline. Sections
used for β-catenin and cyclin D1, detection were heated in a
microwave oven twice for 5 min in citrate buffer (pH 6.0).
Mouse anti-β-catenin and a cyclin D1 monoclonal antibody
(at a dilution of 1:200; Santa Cruz, Santa Cruz, CA) were used
as the primary antibodies. The visualization was performed
by DAB (3,3′-diaminbenzidine chromogen) using the DAKO
LSAB/HRP kit [24]. Negative controls that did not include
the  primary  antibodies  were  also  prepared.  Conjunctiva
tissues and lung epithelial cells were used as the positive
control. The results were evaluated independently by three
observers  and  were  scored  for  the  percentage  of  positive
expression. For cyclin D1 protein, which was expressed only
in  the  nuclei,  we  counted  the  positive  rate  of  nuclear
expression in all epithelial cells. For the β-catenin, which was
expressed  in  the  membrane,  cytoplasm,  and  nuclei,  we
separated  the  expression  site  into  two  groups,  membrane
expression and cytoplasm/nuclear expression. In this study,
three of 150 patients have positive immunostaining in both
membrane and cytoplasm. We placed them in the nuclei/
cytoplasm groups because in the membrane group, the beta-
catenin was expressed only in the membrane. Scores were
indicated as the following: score 0, no positive staining; score
+, from 1% to 10%; score ++, from 11% to 50%; and score +
++, more than 50% positive cells. In this study, scores of +, +
+,  and  +++  were  considered  to  represent  positive
immunostaining, and a score of 0 was classified as negative
immunostaining.
Statistical analysis: A statistical analysis was performed using
the SPSS statistical software program (SPSS Inc., Chicago,
IL).  The  Fisher’s  exact  test  and  χ2  test  were  applied  for
statistical analysis. A p<0.05 was considered to be statistically
significant.
RESULTS
β-catenin and cyclin D1 protein expression in pterygium:
When the free cytoplasmic β-catenin increases, it ultimately
translocates into the nucleus, resulting in the activation of
cyclin  D1  and  c-myc,  which  are  responsible  for  cell
proliferation  and  neoplastic  transformation  [19,20].  We
further analyzed the correlation of β-catenin and cyclinD1
protein expression in pterygium. In the pterygium group, the
β-catenin proteins were detected in 73 (48.7%) patients (Table
1).  Additionally,  as  shown  in  Figure  1,  aberrant  protein
localization of β-catenin was also detected in pterygia. In 73
β-catenin  positive  patients,  60.3%  (44  of  73)  showed
membrane  localization  and  39.7%  (29  of  73)  showed  a
cytoplasmic or nuclear localization (Figure 1A). In the normal
conjunctiva  group,  all  specimens  were  positive  for
immunostaining in the membrane. These results were similar
to those of our previous report [23]. In the pterygium group,
cyclin D1 proteins were detected in 60 (40.0%) patients (Table
1). Cyclin D1 was positive for immunostaining in the nuclei
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2734(Figure 1B). In the normal conjunctiva group, only 2 of 30
specimens were positive for immunostaining in the nuclei.
Correlation of β-catenin and cyclin D1 protein expression:
To understand the relationship between the β-catenin and
TABLE 1. β-CATENIN AND CYCLIN D1 PROTEIN EXPRESSION IN PTERYGIAL AND CONTROL CONJUNCTIVA ANALYZED BY
IMMUNOHISTOCHEMISTRY.
  Pterygium Control
Protein N % N %
β-catenin
Negative 77 51.3 0 0
Positive
Membrane 44 29.3 30 100
Nuclei/Cytoplasm 29 19.4 0 0
Cyclin D1
Negative 90 60.0 28 93.3
Positive 60 40.0 2 6.7
           β-catenin analyzed in this study is based on prior pterygium samples [23].
Figure 1. Representative immunostaining results for β-catenin and cyclin D1. A: the negative control has the first antibody replaced with IgG.
B: β-catenin protein expression detected in the membrane (400×), C, aberrant localization of β-catenin in the cytoplasm/nuclei (400×), and
D, cyclin D1 protein expression in nuclei (400×).
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2735cyclinD1  protein  expression,  the  correlations  of  β-catenin
localization and cyclin D1 protein expression were analyzed
(Table 2). As shown in Table 2, in the 77 cases of β-catenin
negative expression, 74.0% (57 of 77) had cyclin D1 negative
expression  and  26.0%  (20  of  77)  had  positive  nuclear
expression. In the 44 cases of β-catenin membrane expression,
68.2% (30 of 44) had cyclin D1 negative expression, and
31.8%  (14  of  44)  had  positive  nuclear  expression.
Additionally, in the 29 cases of β-catenin nuclear/cytoplasmic
expression, 10.3% (3 of 29) had cyclin D1 negative expression
and 89.7% (26 of 29) had positive nuclear expression. The
cyclin D1 protein nuclear expression in the β-catenin group
showing aberrant protein localization was significantly higher
than in the negative and membrane groups (p<0.0001).
Cyclin D1 protein expression correlated with the grade of
pterygium:  To  understand  whether  the  cyclin  D1  protein
expression was correlated with the pterygium development,
the correlation of cyclin D1 protein expression and the grade
of pterygium was analyzed. As showed in Table 3, expression
of cyclin D1 protein in atrophic, intermediate, and fleshy
groups were, respectively, 34.6% (18 of 52), 31.1% (19 of 42)
and  56.8%  (21  of  37;  p=0.006).  The  cyclin  D1  protein
expression in the fleshy group was significantly higher than
in the other two groups (p=0.006). No significant differences
were found between cyclin D1 protein expression and gender
(p=0.38). Therefore, we suggested that the cyclin D1 protein
may be involved in pterygium progression.
DISCUSSION
Pterygium, previously considered a degenerative process of
the corneal limbus, pterygium is characterized by the invasion
of a fleshy triangle of conjunctival tissue onto the cornea.
Shimmura  et  al.  demonstrated  an  increased  activity  of
telomerase  in  pterygial  epithelial  cells,  indicating  their
hyperproliferative nature [25]. Satoru et al. [26] reported that
increased expression of Ki67, a cell proliferation marker, was
noted  in  pterygia.  We  assume  that  it  is  the  proliferative
capacities of pterygial cells that give pterygia the appearance
of having a mechanism similar to tumorigenesis.
Previous  reports  indicated  that  the  nuclear  β-catenin
associated with TCF/LEF proteins activates target genes, such
as cyclin D1 and c-myc [19,20,27], which leads to cellular
proliferation  and  division  [19,20,27,28].  The  nuclear  β-
catenin involved in the progression of cellular proliferation
has been found in several types of cancers [29]. A previous
study  indicated  that  both  E-cadherin,  and  β-catenin  were
heterogeneously  expressed  in  the  cell  membrane  and
cytoplasm  of  pterygia  [30].  In  addition,  β-catenin
immunoreactivity  also  showed  intensely  in  the  nuclei  of
several epithelial cells [30,31]. These results were similar to
those of our previous report, which indicated that promoter
hypermethylation  of  E-cadherin  may  be  involved  in  the
reduction  of  E-cadherin  protein  expression  observed  in
pterygia [23]. We also provided evidence for the detection of
aberrant protein localization of β-catenin in pterygia [23]. In
the present study, we showed that the expression of cyclin D1,
a downstream gene of β-catenin, was positively correlated
with β-catenin nuclear/cytoplasmic expression. Therefore, we
considered that the activation of cyclin D1 by β-catenin may
be involved in pterygium proliferation.
TABLE 2. RELATIONSHIP OF β-CATENIN PROTEIN LOCALIZATION AND CYCLIN D1 PROTEIN EXPRESSION IN PTERYGIA.
  Cyclin D1  
 Protein Negative % (n=90) Positive % (n=60) p value
β-catenin
Negative (n=77) 57 (74.0) 20 (26.0)  
Positive
Membrane (n=44) 30 (68.2) 14 (31.8)  
Nuclei/Cytoplasm (n=29) 3 (10.3) 26 (89.7) <0.0001
TABLE 3. CORRELATION OF CYCLIN D1 PROTEIN EXPRESSION AND CLINICAL PARAMETERS OF PTERYGIUM.
  Cyclin D1
Parameters Negative (n=90) Positive (n=60) p value
Gender
Female (n=63) 27 11  
Male (n=87) 26 18 0.238
Type
Atrophic (n=53) 34 19  
Intermediate (n=62) 43 19  
Fleshy (n=35) 13 22 0.006
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2736Studies of cyclin D1 expression in pterygium are very few
in number. Kase et al. [32] found that 40% of pterygial tissues
showed  cyclin  D1  positive  immunostaining.  They  also
discussed  that  cyclin  D1  is  induced  through  activator
protein-1  (AP-1)  transactivation  in  pterygial  tissues
chronically exposed to UV radiation [32]. The present study
showed a positive correlation between nuclear cyclin D1 and
nuclear/cytoplasmic  β-catenin  immunostaining.  We  also
found that cyclin D1 protein expression in the fleshy group
was significantly higher than in the atrophic and intermediate
groups (Table 3, p=0.006). Therefore, we considered that the
overexpression of cyclin D1 in pterygia is activated not only
through the activator AP-1 but also by β-catenin.
In conclusion, our study is the first to provide evidence
showing that the cyclin D1 protein may be activated through
β-catenin protein nuclear/cytoplasmic expression. These data
in  our  study  provided  evidence  that  changes  in  β-catenin
signaling may contribute to cell proliferation in pterygium.
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